Categories
Brief Health Care Manufacturing Tech, Media & Telecom

Foxconn iPhone assembly plant under COVID restrictions

Taiwan’s Foxconn has imposed tough COVID-19 control restrictions on its plant in the Chinese city of Zhengzhou that assembles Apple’s iPhone, reports Reuters. The Zhengzhou campus, which is the world’s largest iPhone factory with about 300,000 workers, has banned all eating in and asked workers to take their meals back to their dormitories starting from […]

Categories
Brief Health Care

Shanghai plans to build new COVID quarantine facility

Shanghai plans to build a 3,250-bed COVID-19 quarantine facility on a small island close to its city center as China stands by its stringent zero-COVID controls, rather than relaxing curbs as many other countries have done, reports Retuers. The city awarded a RMB 1.38 billion ($191 million) contract to build the center on Fuxing Island, […]

Categories
Brief Health Care

China approves inhaled COVID-19 vaccine

China’s CanSino Biologics said on Sunday that its recently developed COVID-19 vaccine has been approved by the country’s drug regulator for emergency use as a booster, potentially benefiting its business, reports the South China Morning Post. The inhaled version of CanSino’s adenovirus-vectored COVID-19 vaccine has obtained the green light from the National Medical Products Administration, […]

Categories
Brief Health Care Markets

China Life profits fall by over one-third

China Life Insurance, the nation’s largest life insurer, said profit fell 38% in the first half as declines in the stock market eroded investment returns and pandemic-induced lockdowns hampered policy sales, reports Bloomberg. Net income dropped to RMB 25.42 billion ($3.7 billion), from RMB 40.97 billion a year earlier, the Beijing-based company said in a […]

Categories
Brief Health Care Investment

Taibang raises $300mn

Taibang Biologic Group has raised $300 million from investors including the Abu Dhabi Investment Authority and Singaporean sovereign wealth fund GIC, the Chinese company said Tuesday, reports Nikkei Asia. The biopharmaceutical company, formerly known as China Biologic Products, was previously listed on Nasdaq. It was taken private in April 2021 by a consortium led by […]